Skip to content
Northbank Media science desk Regenerative aesthetics, read at the level of the evidence Reviewed 1 August 2026
Sourcing and manufacture

What a real specification sheet shows

The measurements that constitute proper characterisation of a vesicle preparation, and how to tell a specification from a description.

Section Sourcing and manufactureReviewed 1 August 2026Length 1,332 wordsDesk Northbank Media
Fine luminous graduated traces across a dark measurement field
Generated abstraction of graduated traces. Not data.
The short answer

Proper characterisation of a vesicle preparation uses several measurements that are independent of one another: particle concentration and size distribution, total protein, the ratio between them as a purity indicator, a marker profile including markers that should be absent, and imaging showing particles with the expected morphology.

A specification states what the product will contain within defined limits on every batch. A description states what one batch contained when someone measured it. Most documents in this market are descriptions written in the register of specifications, and telling them apart takes about a minute once you know what to look for.

The measurements that constitute characterisation

Particle concentration and size distribution

How many particles per unit volume, and how their sizes are distributed. Useful, limited, and discussed at length in why a nanoparticle count is not a dose. A distribution curve is far more informative than a mean, because it reveals whether the preparation is one population or several.

Total protein

Straightforward to measure and essential as a denominator. On its own it says little.

Particle to protein ratio

The simplest widely used purity indicator. A preparation with many particles per unit of protein carries relatively little non-vesicular protein. A preparation with few particles per unit of protein is protein-heavy, which in a preparation sold on the vesicle name means much of the material is not the thing named. This single number tells you more than the particle count it derives from.

Marker profile, including negative markers

Detecting proteins expected to be present on or in vesicles supports the identification. Equally important, and much rarer, is testing for markers that should be absent if the preparation is what it claims. Markers of cellular compartments not expected to be exported, for example, indicate cellular debris. A profile that reports only positive markers has tested only for confirmation.

Imaging

Electron microscopy shows whether particles have the expected morphology. It is qualitative and low throughput, and it detects gross problems that scattering-based counts cannot, such as aggregation or a preparation dominated by non-vesicular material.

Sterility, endotoxin and residuals

Covered separately in sterility, endotoxin and cold chain. A characterisation package without them is incomplete for any product applied to breached skin.

Evidence panelEP-19

A published particle count and mean size constitute characterisation of a vesicle preparation.

Proposed mechanism
Measuring particle number and size identifies the product sufficiently for use.
What has been shown
Consensus reporting frameworks in the extracellular vesicle field require multiple independent categories of measurement, including protein-based quantification, at least two categories of marker analysis and single-particle imaging, precisely because size and count alone cannot distinguish vesicles from other particles.
Highest level reached
In vitro only
Main confounders
None material. This is a documentation standard rather than an empirical question.

GradeNOT SUPPORTED

What would change thisNothing would change this. A count and a mean size are two measurements of one property and cannot establish identity. The relevant reporting frameworks are public and a supplier can be asked directly which of their requirements the product meets.

Specification versus description

This distinction is the practical core of the article. A specification says: this product contains between X and Y particles per millilitre, with a particle to protein ratio not less than Z, meeting the following marker criteria, on every batch, verified by the following tests. A description says: analysis of a representative batch found the following.

The difference is release criteria. A specification implies that batches failing the criteria are not released. A description implies that a batch was measured. Only the first tells you anything about the vial in front of you.

Reading a product document
If the document saysIt is telling youAsk
Contains over N particles per millilitreA count, from an unstated platformPer what volume, on what instrument, at what threshold, and is it a release limit or one measurement?
Analysis of a representative batchOne batch was measuredWhat are the release criteria, and what happens to a batch that fails them?
Proprietary isolation technologyA trade nameWhich separation methods, in what order?
Characterised to international standardsA claim about a claimWhich framework, and which of its requirements are met?
Contains the following growth factorsDetection in a sampleInside vesicles or free in solution, and was that distinguished?

What a good document looks like

In our reading of this sector, a document worth taking seriously has four properties. It names methods rather than trade descriptions. It reports at least one measure of purity, not only of quantity. It includes at least one negative result, meaning something tested for and not found. And it distinguishes release criteria from observations.

The third of those is the most telling. Documents that contain only positive findings have been written to persuade. Documents that report a negative control, a marker absent, an assay below the limit of detection, have been written to inform. That is a difference in intent visible on the page.

Why suppliers resist

Some resistance is commercial confidentiality, and some of that is legitimate: nobody expects a manufacturer to publish a process. But release criteria are not a process. Publishing that a product meets a purity threshold discloses no method. The reluctance to publish criteria usually indicates that criteria do not exist, which is a different and more informative fact.

It is worth saying that developing release criteria is genuinely demanding, especially for a product whose active principle is not identified. A supplier who says frankly that they publish batch analyses because they cannot yet define potency criteria is being more useful than one who implies criteria exist. We would rather publish that statement than a confident number.

What we do with this on the site

Our listings record, for each listed supplier, which of these disclosures they make and which they decline. The listing is alphabetical, labelled paid where paid, and it is not a ranking. A supplier cannot buy a better characterisation record, because the record is a statement of what they disclosed, and declining to disclose is itself published. We set that out in the rate card.

Questions readers ask

What should be on a specification sheet for a vesicle product?

Particle concentration and size distribution, total protein, a particle to protein ratio, a marker profile including markers expected to be absent, imaging showing expected morphology, and sterility and endotoxin data. Release criteria should be distinguished from single-batch observations.

What is the difference between a specification and a certificate of analysis?

A specification states the limits every batch must meet. A certificate of analysis reports what one batch measured. A certificate without a specification tells you what was found, not what the product is guaranteed to contain.

Why are negative markers important?

Because testing only for markers expected to be present tests only for confirmation. Testing for markers that should be absent, such as those indicating cellular debris, is what demonstrates the preparation is not contaminated with material it should not contain.

Is a particle count enough?

No. Consensus reporting frameworks in the field require several independent categories of measurement precisely because count and size cannot distinguish vesicles from protein aggregates or lipoprotein particles.

How can I check a document quickly?

Look for numbers with ranges or limits attached rather than single figures, and look for at least one reported negative result. Documents containing only single positive figures are describing one measurement, not specifying a product.

The science briefing

One email a fortnight. What was published in extracellular vesicle and regenerative aesthetics research, what it actually showed, and which claims moved on our grading scale. Written for people who read the methods section.

No spam, unsubscribe in one click. We never pass your address to a third party. See privacy.